Wilmington Savings Fund Society FSB Takes Position in Bath & Body Works, Inc. (NYSE:BBWI)

Wilmington Savings Fund Society FSB purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,234 shares of the company’s stock, valued at approximately $39,000.

Other large investors have also recently made changes to their positions in the company. Bard Financial Services Inc. acquired a new position in Bath & Body Works in the 3rd quarter worth about $412,000. TD Private Client Wealth LLC raised its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after buying an additional 331 shares during the period. Nomura Asset Management Co. Ltd. lifted its position in shares of Bath & Body Works by 30.6% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 137,610 shares of the company’s stock valued at $4,393,000 after buying an additional 32,233 shares in the last quarter. iA Global Asset Management Inc. grew its stake in Bath & Body Works by 1,078.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company’s stock valued at $1,575,000 after acquiring an additional 45,144 shares during the period. Finally, Wellington Management Group LLP purchased a new stake in Bath & Body Works in the 3rd quarter worth $8,129,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell acquired 6,000 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by insiders.

Bath & Body Works Stock Performance

Shares of BBWI opened at $39.27 on Monday. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The stock has a market capitalization of $8.51 billion, a PE ratio of 9.58, a PEG ratio of 1.44 and a beta of 1.83. The stock has a 50-day simple moving average of $33.43 and a 200-day simple moving average of $34.30.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the previous year, the business earned $0.48 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. Analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.04%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a report on Tuesday, November 26th. TD Cowen boosted their price objective on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Evercore ISI lowered their price target on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 28th. Robert W. Baird decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Finally, Wells Fargo & Company upped their target price on shares of Bath & Body Works from $38.00 to $42.00 and gave the stock an “equal weight” rating in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus target price of $42.50.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.